4,510
Views
10
CrossRef citations to date
0
Altmetric
Review

Experimental animal models for rheumatoid arthritis

, &
Pages 193-200 | Received 09 Oct 2017, Accepted 16 Jan 2018, Published online: 12 Feb 2018

References

  • Gibofsky A. Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsis. Am J Manag Care 2014;20:S128–S135.
  • Choy E. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology 2012;51:v3–11.
  • Cross M, Smith E, Hoy D, et al. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014;73:1316–1322.
  • Di Paola R, Cuzzocrea S. Predictivity and sensitivity of animal models of arthritis. Autoimmun Rev 2008;8:73–75.
  • Kannan K, Ortmann RA, Kimpel D. Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiology 2005;12:167–181.
  • Moudgil KD, Kim P, Brahn E. Advances in rheumatoid arthritis animal models. Curr Rheumatol Rep 2011;13:456.
  • Asquith DL, Miller AM, McInnes IB, Liew FY. Animal models of rheumatoid arthritis. Eur J Immunol 2009;39:2040–2044.
  • McNamee K, Williams R, Seed M. Animal models of rheumatoid arthritis: how informative are they? Eur J Pharmacol 2015;759:278–286.
  • Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 1977;146:857–868.
  • Bevaart L, Vervoordeldonk MJ, Tak PP. Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis? Arthritis Rheum 2010;62:2192–2205.
  • Vierboom MP, Jonker M, Bontrop RE, ’t Hart B. Modeling human arthritic diseases in nonhuman primates. Arthritis Res Ther 2005;7:145–154.
  • Vierboom MP, Jonker M, Bontrop RE, Hart BT. Modeling human arthritic diseases in nonhuman primates. Arthritis Res Ther 2005;7:145.
  • Hart BT, Bank RA, De Roos JA, et al. Collagen-induced arthritis in rhesus monkeys: evaluation of markers for inflammation and joint degradation. Rheumatology 1998;37:314–323.
  • Holmdahl R, Lorentzen JC, Lu S, et al. Arthritis induced in rats with non‐immunogenic adjuvants as models for rheumatoid arthritis. Immunol Rev 2001;184:184–202.
  • Tak PP, Gerlag DM, Aupperle KR, et al. Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation. Arthritis Rheum 2001;44:1897–1907.
  • Kim EY, Moudgil KD. The determinants of susceptibility/resistance to adjuvant arthritis in rats. Arthritis Res Ther 2009;11:239.
  • Roy T, Ghosh S. Animal models of rheumatoid arthritis: correlation and usefulness with human rheumatoid arthritis. Indo Amer J Pharm Res 2013;3:6131–6142.
  • Wilder RL. Streptococcal cell wall arthritis. Curr Protoc Immunol 2001;26(15.10):15.10.1–15.10.12.
  • Bakker NP, Van Erck MG, Zurcher C, et al. Experimental immune mediated arthritis in rhesus monkeys. Rheumatol Int 1990;10:21–29.
  • Cromartie WJ, Craddock JG, Schwab JH, et al. Arthritis in rats after systemic injection of streptococcal cells or cell walls. J Exp Med 1977;146:1585–1602.
  • Kimpel D, Dayton T, Kannan K, Wolf RE. Streptococcal cell wall arthritis: kinetics of immune cell activation in inflammatory arthritis. Clin Immunol 2002;105:351–362.
  • Kimpel D, Dayton T, Fuseler J, et al. Splenectomy attenuates streptococcal cell wall–induced arthritis and alters leukocyte activation. Arthritis Rheum 2003;48:3557–3567.
  • Schimmer RC, Schrier DJ, Flory CM, et al. Streptococcal cell wall-induced arthritis: requirements for IL-4, IL-10, IFN-gamma, and monocyte chemoattractant protein-1. J Immunol 1998;160:1466–1471.
  • Schrier DJ, Schimmer RC, Flory CM, et al. Role of chemokines and cytokines in a reactivation model of arthritis in rats induced by injection with streptococcal cell walls. J Leukoc Biol 1998;63:359–363.
  • Rioja I, Bush KA, Buckton JB, et al. Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment. Clin Exp Immunol 2004;137:65–73.
  • Joosten LAB, Abdollahi-Roodsaz S, Heuvelmans-Jacobs M, et al. T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17. Arthritis Rheum 2008;58:98–108.
  • Fife RS. Identification of cartilage matrix glycoprotein in synovial fluid in human osteoarthritis. Arthritis Rheum 1988;31:553–556.
  • Carlsen S, Hansson AS, Olsson H, et al. Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats. Clin Exp Immunol 1998;114:477–484.
  • Vingsbo‐Lundberg C, Saxne T, Olsson H, Holmdahl R. Increased serum levels of cartilage oligomeric matrix protein in chronic erosive arthritis in rats. Arthritis Rheum 1998;41:544–550.
  • Saxne T, Heinegård D. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Rheumatology 1992;31:583–591.
  • Carlsen S, Nandakumar KS, Bäcklund J, et al. Cartilage oligomeric matrix protein induction of chronic arthritis in mice. Arthritis Rheum 2008;158:2000–2011.
  • Schubert D, Maier B, Morawietz L, et al. Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice. J Immunol 2004;172:4503–4509.
  • Glant TT, Finnegan A, Mikecz K. Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics. Crit Rev Immunol 2003;23:199–250.
  • Vingsbo C, Sahlstrand P, Brun JG, et al. Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am J Pathol 1996;149:1675
  • Monach PA, Benoist C, Mathis D. The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease. Adv Immunol 2004;82:217–248.
  • Patten C, Bush K, Rioja I, et al. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology. Arthritis Rheum 2004;50:3334–3345.
  • Kollias G, Papadaki P, Apparailly F, et al. Animal models for arthritis: innovative tools for prevention and treatment. Ann Rheum Dis 2011;70:1357–1362.
  • Maffia P, Brewer JM, Gracie JA, et al. Inducing experimental arthritis and breaking self-tolerance to joint-specific antigens with trackable, ovalbumin-specific T cells. J Immunol 2004;173:151–156.
  • Brackertz D, Mitchell GF, Mackay IR. Antigen‐induced arthritis in mice. Arthritis Rheum 1977;20:841–850.
  • Dawson J, Gustard S, Beckmann N. High-resolution three-dimensional magnetic resonance imaging for the investigation of knee joint damage during the time course of antigen-induced arthritis in rabbits. Arthritis Rheum 1999;42:119–128.
  • Yoshino S, Quattrocchi E, Weiner HL. Suppression of antigen-induced arthritis in Lewis rats by oral administration of type II collagen. Arthritis Rheum 1995;38:1092–1096.
  • Henderson B, Thompson RC, Hardingham T, Lewthwaite J. Inhibition of interleukin-1-induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist. Cytokine 1991;3:246–249.
  • Bendele A. Animal models of rheumatoid arthritis. J Musculoskelet Neuronal Interact 2001;1:377–385.
  • Bockermann R, Schubert D, Kamradt T, Holmdahl R. Induction of a B-cell-dependent chronic arthritis with glucose-6-phosphate isomerase. Arthritis Res Ther 2005;7:R1316.
  • Korganow AS, Ji H, Mangialaio S, et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 1999;10:451–461.
  • Matsumoto I, Staub A, Benoist C, Mathis D. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 1999;286:1732–1735.
  • Kouskoff V, Korganow AS, Duchatelle V, et al. Organ-specific disease provoked by systemic autoimmunity. Cell 1996;87:811–822.
  • Williams RO. Models of rheumatoid arthritis. In: Zollner T, Renz H, Asadullah K, eds. Animal models of T cell-mediated skin diseases. Berlin Heidelberg: Springer; 2005:89–117.
  • Keffer J, Probert L, Cazlaris H, et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 1991;10:4025
  • Li P, Schwarz EM. The TNF-α transgenic mouse model of inflammatory arthritis. Springer Semin Immunopathol 2003;25:19–33.
  • Aidinis V, Plows D, Haralambous S, et al. Functional analysis of an arthritogenic synovial fibroblast. Arthritis Res Ther 2003;5:R140.
  • Williams RO, Feldmann M, Maini RN. Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor α. Ann Rheum Dis 2000;59:i75–i80.
  • Sakaguchi N, Takahashi T, Hata H, et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003;426:454–460.
  • Horai R, Asano M, Sudo K, et al. Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J Exp Med 1998;187:1463–1475.
  • Horai R, Saijo S, Tanioka H, et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 2000;191:313–320.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.